Alkermes plc

NasdaqGS:ALKS Rapport sur les actions

Capitalisation boursière : US$4.7b

Alkermes Gestion

Gestion contrôle des critères 3/4

Le PDG Alkermes est Richard Pops, nommé en Sep2011, a un mandat de 13.17 ans. La rémunération annuelle totale est $ 9.44M, composée du salaire de 12.5% et des bonus 87.5%, y compris les actions et options de la société. détient directement 0.73% des actions de la société, d'une valeur de $ 33.95M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.5 ans et 3.9 ans.

Informations clés

Richard Pops

Directeur général

US$9.4m

Rémunération totale

Pourcentage du salaire du PDG12.5%
Durée du mandat du directeur général13.2yrs
Propriété du PDG0.7%
Durée moyenne d'occupation des postes de direction5.5yrs
Durée moyenne du mandat des membres du conseil d'administration3.9yrs

Mises à jour récentes de la gestion

Recent updates

Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth

Nov 24

Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement

Oct 14
Alkermes plc's (NASDAQ:ALKS) Low P/E No Reason For Excitement

Is Alkermes (NASDAQ:ALKS) A Risky Investment?

Sep 17
Is Alkermes (NASDAQ:ALKS) A Risky Investment?

Alkermes: Fairly Valued After Post-Earnings Bump

Jul 28

Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?

Jul 26
Does Alkermes (NASDAQ:ALKS) Deserve A Spot On Your Watchlist?

Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry

Jul 04
Alkermes plc's (NASDAQ:ALKS) Business And Shares Still Trailing The Industry

The Bottom Fishing Club: Alkermes Has Great Value And Safety

May 17

Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals

May 08
Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals

Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data

Apr 09

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Apr 08
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet

Jan 26

Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Nov 01
Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Nov 01
Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

Jul 15
Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Jun 07
There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Apr 10
Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Mar 20
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes upgraded to neutral at BofA on improved risk/reward outlook

Oct 14

Alkermes holder Sarissa Capital says it may look to increase its stake

Oct 07

Alkermes: Nothing Stands Out As Interesting

Sep 26

Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Aug 29
Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Alkermes initiated at neutral at Piper Sandler as company in transition

Aug 16

Alkermes Q2 2022 Earnings Preview

Jul 26

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Jun 27
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

May 16
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Alkermes: Turning The Tides Towards Profitability

Apr 16

Analyse de la rémunération des PDG

Comment la rémunération de Richard Pops a-t-elle évolué par rapport aux bénéfices de Alkermes?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

US$387m

Jun 30 2024n/an/a

US$386m

Mar 31 2024n/an/a

US$570m

Dec 31 2023US$9mUS$1m

US$519m

Sep 30 2023n/an/a

US$455m

Jun 30 2023n/an/a

US$300m

Mar 31 2023n/an/a

-US$9m

Dec 31 2022US$10mUS$1m

-US$33m

Sep 30 2022n/an/a

-US$129m

Jun 30 2022n/an/a

-US$94m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$9mUS$1m

US$76m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$63m

Mar 31 2021n/an/a

-US$95m

Dec 31 2020US$8mUS$1m

-US$111m

Sep 30 2020n/an/a

-US$74m

Jun 30 2020n/an/a

-US$126m

Mar 31 2020n/an/a

-US$139m

Dec 31 2019US$15mUS$1m

-US$197m

Sep 30 2019n/an/a

-US$201m

Jun 30 2019n/an/a

-US$183m

Mar 31 2019n/an/a

-US$173m

Dec 31 2018US$17mUS$1m

-US$139m

Sep 30 2018n/an/a

-US$139m

Jun 30 2018n/an/a

-US$141m

Mar 31 2018n/an/a

-US$152m

Dec 31 2017US$9mUS$964k

-US$158m

Rémunération vs marché: La rémunération totale de Richard ($USD 9.44M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 6.56M ).

Rémunération et revenus: La rémunération de Richard a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Richard Pops (62 yo)

13.2yrs

Titularisation

US$9,442,066

Compensation

Mr. Richard F. Pops has been the Chief Executive Officer and Director of Alkermes PLC since September 2011 and its Chairman since September 16, 2011. Mr. Pops was the Founder of Genomics Collaborative, Inc...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Richard Pops
Chairman & CEO13.2yrsUS$9.44m0.73%
$ 34.0m
Blair Jackson
Interim Principal Financial Officer3.8yrsUS$4.56m0.098%
$ 4.5m
David Gaffin
Executive VP8.5yrsUS$4.14m0.10%
$ 4.8m
Iain Brown
Senior VP & CFOless than a yearUS$3.21m0.072%
$ 3.3m
Craig Hopkinson
Executive VP of Research & Development and Chief Medical Officer7.5yrsUS$4.23m0.051%
$ 2.4m
Floyd Bloom
Founderno dataUS$324.96kpas de données
Samuel Parisi
Interim Principal Accounting Officer & VP of Financeless than a yearpas de données0.0048%
$ 222.1k
Thomas Harvey
Chief Information Officer & Senior VP of IT6.6yrspas de donnéespas de données
Sandra Coombs
Senior Vice President of Corporate Affairs & Investor Relationsno datapas de donnéespas de données
Stephen Schiavo
Senior VP & Chief Human Resources Officer4.4yrspas de donnéespas de données
Peter Norman
Senior Vice President of Policy & Government Relationsno datapas de donnéespas de données
Declan O'Connor
Senior Vice President of Operations and Environmentno datapas de donnéespas de données

5.5yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de ALKS est chevronnée et expérimentée (5.5 années d'ancienneté moyenne).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Richard Pops
Chairman & CEO13.2yrsUS$9.44m0.73%
$ 34.0m
Brian McKeon
Independent Director3.9yrsUS$482.04k0.023%
$ 1.1m
Nancy Snyderman
Independent Director8.5yrsUS$482.04k0.016%
$ 731.6k
Nancy Lurker
Independent Directorless than a yearpas de donnéespas de données
Shane Cooke
Independent Director6.7yrsUS$449.04k0.062%
$ 2.9m
David Daglio
Independent Director3.9yrsUS$474.04k0.067%
$ 3.1m
Cato Laurencin
Independent Director3yrsUS$459.04k0.012%
$ 570.0k
Frank Wilson
Lead Independent Director5.2yrsUS$486.65k0.015%
$ 719.5k
Christopher Wright
Independent Director2.5yrsUS$463.12k0.0089%
$ 414.9k
Richard Brian Gaynor
Independent Director5.2yrsUS$464.69k0.015%
$ 719.5k
Emily Alva
Independent Director3.5yrsUS$469.04k0.017%
$ 785.6k

3.9yrs

Durée moyenne de l'emploi

62yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de ALKS sont considérés comme expérimentés (ancienneté moyenne 3.9 ans).